Loading clinical trials...
Loading clinical trials...
Purpose of the study : To evaluate the antitumoral effect of two therapeutic procedures and to evaluate their respective toxicity on the CNS.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut Curie
Collaborators
NCT07523737 · Primary Central Nervous System Lymphoma (PCNSL), Diffuse Large B Cell Lymphoma (DLBCL)
NCT07104032 · Relapsed/Refractory Primary Central Nervous System Lymphoma
NCT06712810 · Hematopoietic and Lymphatic System Neoplasm, Histiocytic Sarcoma, and more
NCT07074470 · Primary Central Nervous System Lymphoma (PCNSL)
NCT06175000 · Primary Central Nervous System Lymphoma
Cancérologie Hôpital Sud
Amiens
Chu D'Angers
Angers
CHR Argenteuil
Argenteuil
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions